Skip to content

Director of the Stanford Cancer Institute discusses advances in cancer care and research

Back in 2010, Beverly Mitchell, MD, director of the Stanford Cancer Institute and a professor of medicine, gave us an overview of the landscape of cancer research and treatment. Since that time, significant strides have been made - from the use of genomic analysis, molecular biology, imaging technologies and data management - and these advances have made cancer treatment less toxic and more tailored to the individual patient.

In his latest 1:2:1 podcast, Paul Costello, the medical school's chief communications officer, talks with Mitchell about these advancements and new Stanford initiatives to transform care.

Previously: The big C

Popular posts

Category:
Biomedical research
COVID-19 can infect the inner ear

Researchers say anyone with new on-set hearing loss, tinnitus or vertigo, with exposure to COVID-19, should be tested and monitored.
Category:
Cancer
Can Prozac fight brain cancer?

The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.